Intraosseous BMP implants in rabbits. Inhibitory effect on bone formation

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biomaterials Science

Background:

• The bone harvest chamber model in rabbits facilitates rapid spontaneous bone healing.
• Previous studies indicated BMP-2 inhibition of intraosseous bone formation, contrasting with subfascial applications.
• Conflicting results necessitate re-evaluation of BMP-2's skeletal response in this model.

Purpose of the Study:

• To investigate the consistent inhibition of bone formation by BMP-2 in an intraosseous rabbit model.
• To explore the effects of varying BMP-2 doses, BMP types (BMP-7/OP-1), and carriers (collagen, hydroxyapatite).
• To assess the impact of chamber design and species (rats) on BMP-2's bone healing effects.

Main Methods:

• Utilized a bone harvest chamber model in rabbits and rats for intraosseous and subfascial applications.
• Administered BMP-2 and BMP-7/OP-1 at varying doses (0.6-12 µg/5 mm³) on collagen and hydroxyapatite carriers.
• Modified chamber design to allow extraskeletal tissue contact and examined implant-bone borders.

Main Results:

• Lower BMP-2 doses reduced tissue ingrowth and bone formation.
• BMP-7/OP-1 and BMP-2 on hydroxyapatite carriers also inhibited intraosseous bone formation.
• BMP-2 showed no inhibition when extraskeletal contact was allowed, and no cyst formation was observed.

Conclusions:

• The observed inhibition of bone formation by BMP-2 in this specific intraosseous model is consistent and not attributable to overdose, BMP type, carrier material, or premature differentiation.
• Variations in experimental conditions, including carrier, dose, and model specifics, are critical for understanding BMP-2's role in bone healing.
• Further research is needed to elucidate the mechanisms behind BMP-2's paradoxical inhibitory effect in this particular intraosseous environment.